argenx SE (LON:0QW0)
London · Delayed Price · Currency is GBP · Price in EUR 786.27
-2.93 (-0.37%)
At close: Nov 28, 2025
argenx SE Market Cap
argenx SE has a market cap or net worth of 41.94 billion as of November 28, 2025. Its market cap has increased by 50.84% in one year.
Market Cap
41.94B
Enterprise Value
39.04B
Revenue
2.74B
Ranking
n/a
PE Ratio
36.77
Stock Price
786.27
Market Cap Chart
Since July 10, 2014, argenx SE's market cap has increased from 97.26M to 41.94B, an increase of 43,024.48%. That is a compound annual growth rate of 70.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 41.94B | 40.03% |
| Dec 31, 2024 | 29.95B | 70.09% |
| Dec 29, 2023 | 17.61B | 3.04% |
| Dec 30, 2022 | 17.09B | 24.91% |
| Dec 31, 2021 | 13.68B | 33.96% |
| Dec 31, 2020 | 10.21B | 96.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 219.39B |
| GSK plc | 72.40B |
| Haleon | 33.03B |
| Smith & Nephew | 10.67B |
| ConvaTec Group | 4.60B |
| Hikma Pharmaceuticals | 3.48B |
| HUTCHMED (China) | 1.85B |
| Genus | 1.74B |